Onkos Surgical today announced that it received FDA 510(k) clearance for its BioGrip 3D-printed implant technology. The Parsippany, N.J.–based company designed BioGrip to address the clinical challenge of aseptic loosening in musculoskeletal oncology and complex orthopedic limb salvage surgery. It helps provide bone ingrowth at the bone-implant interface. Get the full story on our sister […]
Onkos Surgical
Onkos Surgical launches Eleos Proximal Tibia
Onkos Surgical today said it has launched its new Eleos Proximal Tibia with BioGrip technology. The implant is designed for use in complex tumor and orthopedic reconstructive procedures. It is touted as the first FDA cleared, 3D printed limb salvage replacement. “The new Eleos Proximal Tibia with BioGrip offers features that are intended to help […]
Onkos Surgical raises $7.6m
Surgical oncology device developer Onkos Surgical filed an SEC Form D to confirm the sale of nearly $7.6 million in equity. The Parsippany, N.J.-based company made its first sale for the new notice on April 21, having now sold approximately $7.57 million. The total offering amount is $12 million, leaving more than $4.4 million remaining […]
Onkos Surgical launches bone scaffolding technology
Onkos Surgical recently launched its GenVie Magnesium Bone Scaffold. The GenVie is a magnesium-based bone void filler with osteoconductive and high compression strength attributes to promote bone repair and regeneration. It is designed for surgically created osseous defects or osseous defects created from traumatic injury to the bone. “We are excited about the launch of […]
Onkos Surgical partners with Integrum for OPRA Implant System
Onkos Surgical this week announced it signed a multi-year agreement with Integrum to expand to market for Integrum’s OPRA Implant System. The collaboration is expected to commence immediately and will focus on expanding the U.S. market for Integrum’s Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System. “We are delighted to partner with Dr. […]
Bone Solutions, Onkos ink private label deal
Bone Solutions said today that it entered into a private label licensing agreement with Onkos Surgical for its OsteoCrete bone void-filling technology. Colleyville, Texas-based BSI’s OsteoCrete is an FDA 510(k)-cleared magnesium-based injectable, moldable solution designed to attaching ligaments and tendons to bone and bone to bone. Parsippany, N.J.-based Onkos Surgical intends to market OsteoCrete under the […]
50 medtech startups you need to know
Medical device industry accelerator MedTech Innovator today announced about 50 medtech startups participating in its annual four-month program. Half are early-stage companies participating in MedTech Innovator’s Accelerator and Showcase program, and the other half are mid-stage companies in the organization’s Showcase program. The list of companies is a who’s who of people around the world […]
Onkos Surgical to use Promimic’s nano-thin HA coating
Onkos Surgical, a surgical oncology device developer, said today that it is working with Promimic AB to commercialize Promimic’s nano-thin hydroxyapatite coating technology for use on limb salvage surgery implants. Hydroxyapatite (HA) is a major component of normal bone and teeth that is already used as a coating on orthopedic implants to promote fixation and […]
Onkos Surgical, Insight Medical partner to test AR-assisted tumor surgery
Surgical oncology device developer Onkos Surgical and orthopedic augmented reality dev Insight Medical Systems said this week they inked a partnership deal looking to explore the use of Insight’s Arvis augmented reality visualization and information system in musculoskeletal oncology. Both companies said they are engaged in a pilot project looking to assess the use of Arvis during […]
Onkos Surgical raises $18m in Series B
Surgical oncology device developer Onkos Surgical said today it closed a $17.6 million Series B financing round. Money in the round will support the expansion of the Parsippany, N.J.-based company’s sales, marketing and R&D platforms. The round was led by Canaan Partners and joined by existing investors 1315 Capital and 3D Systems. “The Onkos team […]
